Abstract
Transforming growth factor-β1 is an important local regulator of bone metabolism, acting downstream of estrogen and cooperatively with vitamin D. The possible association of a C–509→T polymorphism in the promoter region of the transforming growth factor-β1 gene, alone or in combination with a T869→C (Leu10→Pro) polymorphism, with bone mineral density and genetic susceptibility to osteoporosis was investigated in 625 postmenopausal Japanese women. The frequencies of the CC, CT, and TT genotypes of the C–509→T polymorphism in the study population were 24%, 49%, and 27%, respectively. A significant association of C–509→T genotype with bone mineral density was detected: lumbar spine (L2–L4) and total body bone mineral density values were 7% and 5% lower, respectively, in individuals with the TT genotype than in those with the CT or CC genotype. The serum concentration of transforming growth factor-β1 did not vary with C–509→T genotype. Multivariable logistic regression analysis, with adjustment for age, height, body weight, time since menopause, smoking status, body fat mass, and lean mass, revealed a significantly higher frequency of the TT genotype of the C–509→T polymorphism in 286 individuals with osteoporosis than in 170 normal controls. Analysis of combined C–509→T and T869→C genotypes showed that L2–L4 bone mineral density decreases and the prevalence of osteoporosis increases with the number of T alleles. These results suggest that the C–509→T polymorphism, alone or in combination with the T869→C polymorphism, of the transforming growth factor-β1 gene is a genetic determinant of bone mass, and that the number of T alleles in the combined genotype is a risk factor for the genetic susceptibility to osteoporosis in postmenopausal Japanese women.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Yamada, Y., Miyauchi, A., Takagi, Y. et al. Association of the C–509→T polymorphism, alone or in combination with the T869→C polymorphism, of the transforming growth factor-β1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J Mol Med 79, 149–156 (2001). https://doi.org/10.1007/s001090100190
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001090100190